Literature DB >> 5578784

Cellular differentiation of the middle ear lining.

J Sadé.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5578784     DOI： 10.1177/000348947108000312

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN： 0003-4894            Impact factor:   1.547


× No keyword cloud information.
  8 in total

1.  Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide; Hiroshi Shimoda; Seiji Kato
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

2.  Middle ear mucosa and secretory otitis media.

Authors:  J Sadé; Z Weissman
Journal:  Arch Otorhinolaryngol       Date:  1977-05-31

3.  [The reactions of human middle ear mucous membrane (author's transl)].

Authors:  W Arnold
Journal:  Arch Otorhinolaryngol       Date:  1977-04-20

4.  Histopathological evaluation and long-term results of soft tissue preservation technique in cholesteatoma surgery.

Authors:  Harukazu Hiraumi; Shin-Ichi Kanemaru; Makoto Miura; Norio Yamamoto; Tatsunori Sakamoto; Juichi Ito
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-03       Impact factor: 2.503

5.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

Review 6.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

7.  Mucosubstance histochemistry and pathogenesis of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-08       Impact factor: 2.503

8.  Pathogenesis of sinus cholesteatoma.

Authors:  Holger Sudhoff; Mirko Tos
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-30       Impact factor: 3.236
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.